Wilson Troy Edward's Form 4 filing
Avidity Biosciences, Inc. · filed Aug 8, 2025
- Accession no.
- 0001599901-25-000154
- Filed
- Aug 8, 2025
- Trade date
- Aug 6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.28M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wilson Troy EdwardCIK 0001589597 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +22,000 | $12.03 | +$264,660 | 91,425 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −22,000 | $45.00 | −$990,000 | 69,425 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $12.48 | +$93,600 | 76,925 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −7,500 | $45.00 | −$337,500 | 69,425 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −15,000 | $45.00 | −$675,000 | 285,000 | Indirect | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −15,000 | $45.00 | −$675,000 | 285,000 | Indirect | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −17,777 | $45.00 | −$799,965 | 17,776 | Indirect | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −17,777 | $45.00 | −$799,965 | 17,776 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −22,000 | $0.00 | $0 | 0 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 14,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.